政府新闻

City News

美国生物技术公司莫德纳将在上海投资   2023-07-06

 


A primary school student gets administered with vaccine against COVID-19 at a vaccination site in east China's Shanghai, Oct. 30, 2021.

U.S. biotechnology company Moderna inked a strategic cooperation agreement with local authorities in Shanghai on Wednesday, planning to invest on the Chinese mainland for the first time, with its current mRNA medicines pipelines to be set up in the city's Minhang District.

During the signing ceremony held Wednesday in Shanghai, the company announced cooperation in biomedical investment, research and development (R&D), production, and commercialization with the municipal commission of economy and informatization and the district government of Minhang.

The company's first investment project on the Chinese mainland will center on the market demands of the country. It will set up its mRNA medicines pipelines in Minhang and conduct clinical trials on new medicines, apply for putting its products on the market, and produce and sell them in China.

Moderna has registered a biotech company branch in Minhang District and established its Chinese headquarters there. It plans to set up several wholly-owned subsidiaries under the Chinese headquarters, which will cover investment management, R&D, sales, production, and so on, and to build a plant in China.

As one of the world's leading mRNA vaccine developers, Moderna focuses on cancer immunotherapy, including mRNA-based medicine R&D and virus prevention technologies.

Source: Xinhua

 

来源:Xinhua

 


注册记者登录

 

 

记者点此免费注册 | 忘记密码

采访申请流程

06月08日 21315203 受理中
02月16日 21315167 已办结
01月26日 21315166 已办结

咨询申请流程

06月12日 02131545 已办结
05月12日 02131544 已办结
05月06日 02131541 已办结

查看全部 »

共性问题提示

Q: 问:如果想要迅速了解上海这座...
A: 答:请注册登陆本网站“今日上...
Q: 问:如果您想在上海进行采访,...
A: 答:(1) 请注册登陆本网站...
Q: 在哪里可以买到上海的地图?
A: 上海各大书店中均有出售,一些...